Cocrystal Pharma, Inc. (COCP)
1.135
+0.02
(+2.25%)
USD |
NASDAQ |
Aug 25, 16:00
1.135
0.00 (0.00%)
After-Hours: 19:59
Cocrystal Pharma Total Assets (Quarterly) : 4.649M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.649M |
| March 31, 2026 | 7.426M |
| December 31, 2025 | 9.712M |
| September 30, 2025 | 10.45M |
| June 30, 2025 | 8.505M |
| March 31, 2025 | 10.66M |
| December 31, 2024 | 13.46M |
| September 30, 2024 | 16.23M |
| June 30, 2024 | 21.57M |
| March 31, 2024 | 26.55M |
| December 31, 2023 | 31.26M |
| September 30, 2023 | 32.61M |
| June 30, 2023 | 36.28M |
| March 31, 2023 | 37.84M |
| December 31, 2022 | 40.84M |
| September 30, 2022 | 45.65M |
| June 30, 2022 | 52.38M |
| March 31, 2022 | 75.37M |
| December 31, 2021 | 79.39M |
| September 30, 2021 | 82.60M |
| June 30, 2021 | 87.42M |
| March 31, 2021 | 53.85M |
| December 31, 2020 | 54.24M |
| September 30, 2020 | 53.22M |
| June 30, 2020 | 40.48M |
| Date | Value |
|---|---|
| March 31, 2020 | 42.84M |
| December 31, 2019 | 28.53M |
| September 30, 2019 | 73.44M |
| June 30, 2019 | 74.91M |
| March 31, 2019 | 76.29M |
| December 31, 2018 | 88.34M |
| September 30, 2018 | 124.17M |
| June 30, 2018 | 126.32M |
| March 31, 2018 | 120.72M |
| December 31, 2017 | 139.56M |
| September 30, 2017 | 122.25M |
| June 30, 2017 | 124.34M |
| March 31, 2017 | 122.52M |
| December 31, 2016 | 148.80M |
| September 30, 2016 | 220.90M |
| June 30, 2016 | 220.15M |
| March 31, 2016 | 225.17M |
| December 31, 2015 | 240.70M |
| September 30, 2015 | 266.16M |
| June 30, 2015 | 269.13M |
| March 31, 2015 | 268.60M |
| December 31, 2014 | 267.47M |
| September 30, 2014 | 11.64M |
| June 30, 2014 | 12.97M |
| March 31, 2014 | 10.48M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| CNBX Pharmaceuticals, Inc. | 0.0128M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 675.10M |
| Fulcrum Therapeutics, Inc. | 323.95M |
| Definium Therapeutics, Inc. | 1.113B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.605M |
| Shareholders Equity (Quarterly) | 1.044M |
| Debt to Equity Ratio | 1.284 |
| Current Ratio | 1.237 |
| Net Debt Paydown Yield | 0.54% |